Loader
Latest News
HR8454: Medical Marijuana and Cannabidiol Research Expansion Act
20787
wp-singular,page-template-default,page,page-id-20787,wp-theme-bridge,bridge-core-3.3.4.9,qode-optimizer-1.2.2,qode-page-transition-enabled,ajax_fade,page_not_loaded,,qode_grid_1400,side_menu_slide_from_right,qode-theme-ver-30.8.9.1,qode-theme-bridge,qode_header_in_grid,wpb-js-composer js-comp-ver-9.0.1,vc_responsive
 
HR8454
Medical Marijuana and Cannabidiol Research Expansion Act

1
Roll Calls
221
Yea (latest vote)
73
Nay (latest vote)
House
2022-07-26 – 2022-07-26

About HR8454

Medical Marijuana and Cannabidiol Research Expansion Act

Policy Area: Crime and Law Enforcement

Sponsor: Rep. Blumenauer, Earl [D-OR-3] (D-OR)

Latest Action (2022-12-02): Became Public Law No: 117-215.

Summary

Medical Marijuana and Cannabidiol Research Expansion Act This act establishes a new, separate registration process to facilitate research on marijuana. Specifically, the act directs the Drug Enforcement Administration (DEA) to follow procedures specified in the act to register (1) practitioners to conduct marijuana research, and (2) manufacturers to supply marijuana for the research. The act allows certain registered entities (including institutions of higher education, practitioners, and manufacturers) to manufacture, distribute, dispense, or possess marijuana or cannabidiol (CBD) for the purposes of medical research. Additionally, the act directs the DEA to register manufacturers and distributors of CBD or marijuana for the purpose of commercial production of an approved drug that contains marijuana or its derivative. Finally, the act includes various other provisions, including provisions that require the DEA to assess whether there is an adequate and uninterrupted supply of marijuana for research purposes; prohibit the Department of Health and Human Services (HHS) from reinstating the interdisciplinary review process for marijuana research; allow physicians to discuss the potential harms and benefits of marijuana and its derivatives (including CBD) with patients; and require HHS, in coordination with the National Institutes of Health and relevant federal agencies, to report on the therapeutic potential of marijuana for various conditions such as epilepsy, as well a

Subjects: Alternative treatments, Congressional oversight, Drug safety, medical device, and laboratory regulation, Drug therapy, Drug trafficking and controlled substances, Drug, alcohol, tobacco use, Health personnel, Licensing and registrations

Who Voted How on HR8454

Filter by Yea, Nay, or Absent

Vote Breakdown — HR8454

How members voted on HR8454. 296 total positions across all roll calls for this bill.

Member Date Question Vote Result
Robert B. Aderholt (R-Alabama) 2022-07-26 2/3 Yea-And-Nay Nay Passed
Jake Auchincloss (D-Massachusetts) 2022-07-26 2/3 Yea-And-Nay Yea Passed
Mark E. Amodei (R-Nevada) 2022-07-26 2/3 Yea-And-Nay Yea Passed
Alma S. Adams (D-North Carolina) 2022-07-26 2/3 Yea-And-Nay Yea Passed
Pete Aguilar (D-California) 2022-07-26 2/3 Yea-And-Nay Yea Passed
Rick W. Allen (R-Georgia) 2022-07-26 2/3 Yea-And-Nay Nay Passed
Jodey C. Arrington (R-Texas) 2022-07-26 2/3 Yea-And-Nay Nay Passed
Sanford D. Bishop (D-Georgia) 2022-07-26 2/3 Yea-And-Nay Yea Passed
Cliff Bentz (R-Oregon) 2022-07-26 2/3 Yea-And-Nay Nay Passed
Stephanie I. Bice (R-Oklahoma) 2022-07-26 2/3 Yea-And-Nay Yea Passed
Lauren Boebert (R-Colorado) 2022-07-26 2/3 Yea-And-Nay Nay Passed
Gus M. Bilirakis (R-Florida) 2022-07-26 2/3 Yea-And-Nay Nay Passed
Vern Buchanan (R-Florida) 2022-07-26 2/3 Yea-And-Nay Yea Passed
Suzanne Bonamici (D-Oregon) 2022-07-26 2/3 Yea-And-Nay Yea Passed
Joyce Beatty (D-Ohio) 2022-07-26 2/3 Yea-And-Nay Yea Passed
Andy Barr (R-Kentucky) 2022-07-26 2/3 Yea-And-Nay Yea Passed
Julia Brownley (D-California) 2022-07-26 2/3 Yea-And-Nay Yea Passed
Ami Bera (D-California) 2022-07-26 2/3 Yea-And-Nay Yea Passed
Brian Babin (R-Texas) 2022-07-26 2/3 Yea-And-Nay Nay Passed
Donald S. Beyer (D-Virginia) 2022-07-26 2/3 Yea-And-Nay Yea Passed
Mike Bost (R-Illinois) 2022-07-26 2/3 Yea-And-Nay Nay Passed
Brendan F. Boyle (D-Pennsylvania) 2022-07-26 2/3 Yea-And-Nay Yea Passed
Don Bacon (R-Nebraska) 2022-07-26 2/3 Yea-And-Nay Yea Passed
Jim Banks (R-Indiana) 2022-07-26 2/3 Yea-And-Nay Nay Passed
Nanette Diaz Barragán (D-California) 2022-07-26 2/3 Yea-And-Nay Yea Passed
Jack Bergman (R-Michigan) 2022-07-26 2/3 Yea-And-Nay Yea Passed
Andy Biggs (R-Arizona) 2022-07-26 2/3 Yea-And-Nay Nay Passed
Lisa Blunt Rochester (D-Delaware) 2022-07-26 2/3 Yea-And-Nay Yea Passed
Ted Budd (R-North Carolina) 2022-07-26 2/3 Yea-And-Nay Nay Passed
Troy Balderson (R-Ohio) 2022-07-26 2/3 Yea-And-Nay Yea Passed
James R. Baird (R-Indiana) 2022-07-26 2/3 Yea-And-Nay Yea Passed
Tim Burchett (R-Tennessee) 2022-07-26 2/3 Yea-And-Nay Yea Passed
Shontel M. Brown (D-Ohio) 2022-07-26 2/3 Yea-And-Nay Yea Passed
Ken Calvert (R-California) 2022-07-26 2/3 Yea-And-Nay Yea Passed
James E. Clyburn (D-South Carolina) 2022-07-26 2/3 Yea-And-Nay Yea Passed
Kat Cammack (R-Florida) 2022-07-26 2/3 Yea-And-Nay Yea Passed
John R. Carter (R-Texas) 2022-07-26 2/3 Yea-And-Nay Nay Passed
Tom Cole (R-Oklahoma) 2022-07-26 2/3 Yea-And-Nay Yea Passed
Ed Case (D-Hawaii) 2022-07-26 2/3 Yea-And-Nay Yea Passed
Jim Costa (D-California) 2022-07-26 2/3 Yea-And-Nay Yea Passed
Emanuel Cleaver (D-Missouri) 2022-07-26 2/3 Yea-And-Nay Yea Passed
Henry Cuellar (D-Texas) 2022-07-26 2/3 Yea-And-Nay Yea Passed
Kathy Castor (D-Florida) 2022-07-26 2/3 Yea-And-Nay Yea Passed
Yvette D. Clarke (D-New York) 2022-07-26 2/3 Yea-And-Nay Yea Passed
Steve Cohen (D-Tennessee) 2022-07-26 2/3 Yea-And-Nay Yea Passed
Joe Courtney (D-Connecticut) 2022-07-26 2/3 Yea-And-Nay Yea Passed
André Carson (D-Indiana) 2022-07-26 2/3 Yea-And-Nay Yea Passed
Judy Chu (D-California) 2022-07-26 2/3 Yea-And-Nay Yea Passed
Eric A. "Rick" Crawford (R-Arkansas) 2022-07-26 2/3 Yea-And-Nay Nay Passed
Joaquin Castro (D-Texas) 2022-07-26 2/3 Yea-And-Nay Yea Passed

Showing 50 of 296 positions. JavaScript-enabled view supports filter by Yea/Nay/Absent and pagination.

Interactive features require JavaScript. Static data shown above.

Other Contested Bills

Interactive features require JavaScript. Static data shown above.

Frequently Asked

What is HR8454?

HR8454 is the Medical Marijuana and Cannabidiol Research Expansion Act, introduced in the House of the 119th U.S. Congress by Rep. Blumenauer, Earl [D-OR-3] (D-OR). Medical Marijuana and Cannabidiol Research Expansion Act This act establishes a new, separate registration process to facilitate research on marijuana. Specifically, the act directs the Drug Enforcement Administration (DEA) to follow procedures specified in the act to register (1) practitioners to conduct marijuana research, and (2) manufacturers to supply marijuana for the research.

Who sponsored HR8454?

HR8454 was sponsored by Rep. Blumenauer, Earl [D-OR-3] (D-OR). Cosponsors and roll-call positions are listed on this page.

What is the current status of HR8454?

As of 2022-12-02, HR8454 Became Public Law No: 117-215..

How did Congress vote on HR8454?

HR8454 has had 1 roll-call vote on record. The most recent: 2022-07-26 — 2/3 Yea-And-Nay (Passed).

What policy area does HR8454 cover?

HR8454 is categorized under "Crime and Law Enforcement." Browse other bills in this area at /topic-crime-and-law-enforcement/.

Where can I see all member positions on HR8454?

Each member’s vote is shown on this page, with party affiliation, state, and the official vote question. Click any member to see their full voting record.